Pharma Journalist -

Oscotec Inc. the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, announced a new research development and licensing agreement. Oscotec…
Read More...

Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few years,…
Read More...

SMi reports: Exclusive Co-Chair letter invitation released for the upcoming Pre-Filled Syringes West Coast 2021 SMi are delighted to have Tina Rees, Associate Director, Regeneron…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and…
Read More...

Boehringer Ingelheim and Gubra announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the…
Read More...

Partner Therapeutics, Inc. (PTx) announced top-line results of the investigator-led SARPAC (Sargramostim in Patients with Acute Hypoxic Respiratory Failure and Acute COVID-19) study of…
Read More...

Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany, a leading…
Read More...

SMi Reports: Exploring the challenges, practices and drivers in the aftermath of the transition for Parallel Trade Join us at SMi’s 15th annual Parallel Trade Conference bringing…
Read More...

Johnson & Johnson (the Company) announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine,…
Read More...